Sub-specialties: Benign Prostatic Hyperplasia, Female Urology, Incontinence, Neurourology, Reconstructive Urology, Urodynamics
Conditions Treated by this Doctor:
Benign Prostatic Hyperplasia (BPH), Circumcision, Erectile Dysfunction, Impotence (Erectile dysfunction), Kidney Cancer, Kidney Stones, Overactive Bladder, Pelvic Floor Disorders, Pelvic Floor Exercises, Penis Abnormality (Hypospadias), Stress Urinary Incontinence, Testicular Cancer, Undescended Testicles, Urinary Difficulties, Urinary Incontinence, Urinary Incontinence, Urinary Stones (Kidney Stones), Urinary Tract Infection (UTI).
Dr Park graduated from Barts and The London School of Medicine and Dentistry, Queen Mary University of London in the year 2006. After completing the UK’s two year Foundation training program in 2008, he moved to Singapore where he completed his basic surgical training. During this time, he qualified for membership of the Royal College of Surgeons of England. He went on to advanced surgical training in urology, which was completed in the year 2015. In the same year, he became a fellow in Urology at the Royal College of Physicians and Surgeons of Glasgow.
Dr Park received the Health Manpower Development Plan (HMDP) fellowship in 2017 to subspecialise in reconstructive and functional urology at The Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust in the UK. He is currently a Senior Consultant urological surgeon with the Department of Urology at Changi General Hospital (CGH).
• Park JJ, Chapple CR. Chapter 7 - Combination pharmacotherapy for OAB. Book Title: Contemporary Pharmacotherapy for Overactive Bladder. Springer. (Accepted for publication in 2018)
• Park JJ, Chapple CR. Update on alpha-blocker monotherapy in LUTS. BJUI Knowledge short e-learning module. (accepted for publication in 2017)
• Kwong HL, Tay Y-K, Park JJ. Trousseau syndrome presenting with penile gangrene. JAAD Case Reports. 2017;3(2):100-102.
• Chen YT, Ahmad MK, Ng LS, Seah JT, Park JJ, Tan TY. In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections. Annals of the Academy of Medicine, Singapore. 2016 Jun;45(6):245.
Subscribe to our mailing list to get the updates to your email inbox...